Pulmonx Corp
LUNG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001127537
In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Pulmonx Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 102 | 115 | +13 |
| Shares | 34.7M | 33.9M | −837.0K (−2.4%) |
| Value | $388.0M | $444.0M | +$56.0M (+14.4%) |
New holders (22)
Institutions that held Pulmonx Corp at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (9)
Institutions that held Pulmonx Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Novo Holdings A/S | 510,555 | $5.71M |
| Marshall Wace, LLP | 117,268 | $1.31M |
| Schonfeld Strategic Advisors LLC | 25,566 | $285.8K |
| Handelsbanken Fonder AB | 16,100 | $180.0K |
| Lido Advisors, LLC | 13,575 | $151.8K |
| Dynamic Technology Lab Private Ltd | 13,379 | $150.0K |
| Aquatic Capital Management LLC | 4,400 | $49.0K |
| Psagot Value Holdings Ltd. / (Israel) | 331 | $4.00K |
| Ellevest, Inc. | 17 | $190 |